国内首例不停跳！一体化全磁悬浮双心室辅助系统

Core Insights - The article highlights the significant advancements in cardiac treatment, particularly focusing on the DuoCor™ dual-chamber assist device developed by Shenzhen Core Medical Technology Co., Ltd. [3][9] - The device addresses the limitations of traditional left ventricular assist devices (LVADs) by providing support for both left and right heart functions, thus expanding its applicability for heart failure patients [3][4] - The increasing prevalence of heart failure, with projections indicating a rise from 11.58 million patients in 2021 to 16.33 million by 2030 in China, underscores the urgent need for innovative solutions in this field [4][8] Company Overview - Shenzhen Core Medical Technology Co., Ltd. was established in August 2016 and focuses on the research and production of high-end innovative medical devices, particularly mechanical circulatory support systems [15] - The company has developed the DuoCor™ device, which is the world's first fully magnetic levitation integrated dual-chamber assist system, designed to cater to the anatomical characteristics of the Asian population [9][19] - Core Medical has achieved significant market presence, with a reported 46% market share for its Corheart® 6 device, which has demonstrated a one-year survival rate of 96% and a two-year survival rate of 94% [19] Product Features - The DuoCor™ device consists of two micro-pumps, a flow regulation system, a power management module, and a monitoring device, with each pump weighing approximately 90 grams, making it lightweight compared to international counterparts [9][17] - The device utilizes an integrated external control system that allows for flexible configurations to simulate natural heart function, thereby improving patient outcomes [11][17] - The design minimizes infection risks by having only one percutaneous cable exiting the body, significantly reducing the potential for complications [17] Clinical Applications - The DuoCor™ device is suitable for patients with left, right, and dual heart failure, providing comprehensive hemodynamic support and improving both heart function and quality of life [13][19] - The successful implantation of the DuoCor™ device in a patient under continuous heart motion marks a significant milestone in the clinical application of artificial heart technologies [4][14] - The device has undergone extensive preclinical validation and is currently in multi-center clinical application research, indicating its readiness for broader clinical use [9][14]